Fig. 4From: MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot studyFrequency of illicit opioid abstinence during and after MySafeRx (based on weekly toxicology)Back to article page